The one-time gene therapy Itvisma will now be available for people with SMA of all ages in the European Union after winning ...

A study found Evrysdi (risdiplam) helps the body produce more SMN, and also revealed genetic differences between SMA types 2 and 3.

For guest writer Maria Llave, having consistent access to Medicaid provides peace of mind, enabling her to focus on her future.

Columnist Kevin Schaefer says that the days of having a hospital room as a place of residency are hopefully behind him, which ...

While attending concerts, columnist Connie Chandler was frustrated that she was unable to express joy. Then she found a clap ...